May 15, 2025

Chemotherapy-Free Triplet in Previously Treated HR-Positive, HER2-Positive Advanced Breast Cancer

In a phase IIa study reported in The Lancet Oncology, Escrivá-de-Romani et al evaluated whether the chemotherapy-free triplet of the HER2-targeted bispecific antibody zanidatamab plus palbociclib and ...

The ASCO Post

May 15, 2025

Breast Parenchymal Phenotypes and Risk of Breast Cancer

Six parenchymal phenotypes were established that may be associated with a higher risk of developing breast cancer. Studies of these phenotypes identified by radiomics on mammograms demonstrated that t...

The ASCO Post

May 09, 2025

Is Active Monitoring a Safe Option for Patients With Ductal Carcinoma In Situ?

With right-sizing treatment an aim of many treatment approaches in breast cancer today, ductal carcinoma in situ (DCIS), as well as its overtreatment, has become a potential target of change. Which pa...

The ASCO Post

May 08, 2025

Collaborative Strategy Involving AI, Human Task-Sharing Could Help Minimize Mammogram Costs

Ahsen et al evaluated the economic feasibility of incorporating artificial intelligence (AI) into mammography screening within health-care settings, considering full or partial integration. The findin...

The ASCO Post

May 08, 2025

Breast Cancer Radiotherapy: 1- vs 3-Week Course

Researchers have examined the safety and efficacy of a 1-week course of postsurgery radiotherapy compared with a traditional 3-week regimen in patients with early-stage breast cancer, according to fin...

The ASCO Post

April 30, 2025

AACR 2025: Trends in Breast Cancer Incidence for Women Between the Ages of 20 and 49

Breast cancer deaths among women between the ages of 20 and 49 declined significantly across all breast cancer subtypes and racial/ethnic groups from 2010 to 2020, with marked declines starting after ...

The ASCO Post

April 25, 2025

Omission of Endocrine Therapy in Estrogen Receptor–Low, Early-Stage Breast Cancer

In a study reported in the Journal of Clinical Oncology, Choong et al looked at whether the omission of endocrine therapy in patients with estrogen receptor–low (1%–10% on immunohistochemistry), early...

The ASCO Post

April 24, 2025

Raising Awareness of Inflammatory Breast Cancer

In late January 2013, while playing with my young son, I noticed my left breast seemed slightly larger than my right breast. Although, at the time, I had no idea this type of swelling is a hallmark of...

The ASCO Post

April 18, 2025

CAP Issues New and Updated Cancer Protocols

New protocols for endocrine tumors and updated existing protocols for breast cancer diagnoses are now available from the College of American Pathologists (CAP).

The ASCO Post